Blocking EGFR signal transduction can increase tumor sensitivity to radiotherapy and chemotherapy, emphasizing the significance of EGFR as a target gene in the therapeutic approach to cervical carcinoma [65]. This evidence concerns the gene EGFR and neoplasm.